Antiplatelet agents: current drugs and future trends.
Antiplatelet drugs in clinical use are discussed in terms of their mechanisms of action and the relevancy of that to the physiology of platelets and the pathophysiology of arterial thrombosis. Current clinical usage is outlined in detail for each drug. Experimental antiplatelet drugs also are discussed.
Messmore
Harry L
HL
Hines Veteran's Affairs Hospital, Hines, IL 60141, USA. hlmehd64@aol.com
Jeske
Walter P
WP
Wehrmacher
William
W
Coyne
Erwin
E
Mobarhan
Sohrab
S
Cho
Leslie
L
Leya
Fred S
FS
Moran
John F
JF
D001792:Blood Platelets / Q000187:drug effects / Q000378:metabolism / Q000502:physiology; D002318:Cardiovascular Diseases / Q000175:diagnosis / Q000188:drug therapy; D005544:Forecasting; D006801:Humans; D010975:Platelet Aggregation Inhibitors / Q000009:adverse effects / Q000145:classification / Q000627:therapeutic use*; D016896:Treatment Outcome
D010975:Platelet Aggregation Inhibitors